Dr. Hemant Malhotra is presently Director, Oncology Services & Professor & Head, Department of Medical Oncology at the Sriram Cancer Center & Super speciality center of the Mahatma Gandhi College Hospital, Jaipur. Since superannuating after more than three decades of government service where he was the PHOD, Department of Medicine and Head of the division of Medical Oncology at the Birla Cancer Center, SMS Medical College, Jaipur, he now working full time at the MGMCH.
Dr. Malhotra graduated and post-graduated at the top of his batch from the SMS Medical College and after fellowships at Tata Memorial Cancer Center, Mumbai (1989 to 1991); Cornell Medical Center, New York and Memorial Sloan Kettering Cancer Center, New York, set up the Medical Oncology division in the department of Medicine at the SMS Hospital in 1991, the first in the state of Rajasthan. He also established a Bone Marrow Transplantation Unit at the SMS and his team has successfully done the first-ever autologous bone marrow transplantation in the state of Rajasthan.
Dr. Malhotra has more than three decades of treating cancer patients in the state of Rajasthan is a well-recognized and respected teacher. Many of his students are now senior medical oncologists spread all over the country and heading their own departments.
Dr. Malhotra has to his credit more than 300 international and national publications and presentations and is an office bearer and member of many international and national societies and organizations. Dr. Malhotra is keenly interested in clinical research and has completed more than 40 investigator initiated and industry sponsored pivotal clinical trial as Principal Investigator. Dr. Malhotra has investigator-initiated trials and projects in several diseases, especially Chronic Myeloid Leukemia. He is/was president/past president of most of the major national societies, and sits on several National and Government advisory committees of CDSCO, ICMR and Government of India.
-
-
-
International Awards
|
S. No.
|
Name of award / name of fellowship
|
Year
|
Name of professional organization awarded
|
|
1
|
Varoon mahajan international oncology fellowship for usa
|
1996
|
Cornell hospital
|
|
2
|
International cancer technology transfer
|
1998
|
Uicc
|
|
3
|
Siop fellowship
|
2000
|
International society for pediatric oncology, amsterdom, holland
|
|
4
|
Ficp
|
2003
|
Indian college of physicians
|
|
5
|
Plaque of honor
|
2010
|
Carcinogenesis foundation usa
|
|
6
|
Frcp london
|
2012
|
Royal college of physicians
|
|
7
|
Sfo oration award
|
2014
|
Saarc foundation of oncology
|
|
8
|
Facp
|
2016
|
American college of physicians
|
|
9
|
Frcp edinburgh
|
2016
|
Royal college of physicians edinburgh
|
|
10
|
Icmlf prize
|
2018
|
International chronic myeloid leukemia foundation
|
|
11
|
Life time achievement award
|
2022
|
Asian society of mastology
|
|
12
|
Outstanding contribution to cancer care
|
2023
|
An international symposium on precision oncology & personalised medicine
|
National Awards
|
S. No.
|
Name of award
|
Year
|
Professional organization
|
|
1
|
Nams award
|
1996
|
Nams
|
|
2
|
National orations and fellowships
|
2004
|
Indian college of physician
|
|
3
|
National orations and fellowships
|
2005
|
International medical science accademy
|
|
4
|
National orations and fellowships
|
2014
|
Saarc foundation oof oncology
|
|
5
|
National orations and fellowships
|
2015
|
Indian society of medical & paediatric oncology
|
|
6
|
Society award
|
2015
|
Rajasthan government state award
|
|
7
|
National orations and fellowships
|
2022
|
Hematology update
|
|
8
|
Nams
|
2023
|
National academy of medical sciences (india), rajasthan chapter
|
|
9
|
National orations and fellowships
|
2023
|
49th indian cooperative oncology network conference
|
Public Honors
|
S. No.
|
Name of award
|
Year
|
Professional organization
|
|
1
|
Society award
|
1994
|
Association of physicians of india
- raj chapter
|
|
2
|
Society award
|
2009
|
Jaipur medical association
|
|
3
|
Society award
|
2010
|
Carcinogenesis foundation usa
|
|
4
|
Society award
|
2014
|
Sms medical college jaipur
|
|
5
|
Society award
|
2015
|
Rajasthan government state award
|
|
6
|
Society award
|
2016
|
India international friendship society
|
|
7
|
Society award
|
2017
|
India international friendship society
|
|
8
|
Society award
|
2017
|
National lung cancer conference
|
|
9
|
Society award
|
2017
|
Private hospital nursing home society
|
|
10
|
Society award
|
2017
|
Rajasthan medical council
|
|
11
|
Society award
|
2017
|
India society of hematology & blood transfusion - manorma sapre oration award
|
|
12
|
Society award
|
2018
|
Mahatma gandhi university
|
|
13
|
Society award
|
2018
|
Times of india
|
|
14
|
Society award
|
2019
|
Private hospital nursing home society
|
|
15
|
Society award
|
2019
|
Mahatma gandhi university
|
|
16
|
Society award
|
2021
|
Mahatma gandhi university
|
|
17
|
Society award
|
2021
|
Mahatma gandhi university
|
|
18
|
Society award
|
2022
|
Indian society for clinical research-15th annual conference
|
|
19
|
Society award
|
2022
|
Indian association for cancer research- 41st annual conference of the indian association for cancer research
|
|
20
|
Society award
|
2022
|
National conclave medical buzz
|
|
21
|
Society award
|
2022
|
Private hospital & nursing home society
|
|
22
|
Society award
|
2022
|
Indian society of medical & paediatric oncology
|
|
23
|
Society award
|
2022
|
20th annual conference rgcon-2022
|
|
24
|
Society award
|
2022
|
Jaipur medical association
|
|
25
|
Society award
|
2022
|
2nd dr. Advani’s legendary oncology series (dalos) conference
|
|
26
|
Society award
|
2022
|
Midcon, 2022
|
|
27
|
Society award
|
2022
|
Dte conference, 2022
|
|
28
|
Society award
|
2022
|
3rd tmc medical oncology alumni meet- tata memorial centre medical oncology aliumni association
|
|
29
|
Society award
|
2022
|
Trends of transformation in oncology- indian perspective conference
|
|
30
|
Society award
|
2023
|
Sms medical college jaipur
|
|
31
|
Society award
|
2023
|
The economic times
|
|
32
|
Society award
|
2023
|
Jaipur medical association
|
|
33
|
Society award
|
2023
|
3rd dr. Advani’s legendary oncology series (dalos) conference
|
|
34
|
Society award
|
2023
|
Precision oncology & molecular oncology conference 2023
|
|
34
|
Society award
|
2023
|
Sms medical college jaipur
|
-
Member, Indian Council for Medical Research (ICMR) committee for National Cancer Treatment Guidelines on CML, Soft Tissue Sarcoma & Cancer Buccal mucosa
-
Chairman, ICMR committee for National Cancer Treatment Guidelines on Multiple Myeloma
-
Member, Oncology Project Review Committee, ICMR
-
Member, Medical Oncology Task Force, National Cancer Control Program, Government of India (GOI)
-
Member, Scientific Advisory Committee, Institute of Cytology & Preventive Oncology, ICMR, GOI
-
Technical Expert to the Drug Controller of India on Oncology related new formulations and drugs
-
Member, National Task Force of ICMR for Immuno-phenotyping of Hemato-lymphoid malignancies
-
Member, Scientific Advisory Board, International Chronic Myeloid Leukemia Foundation (iCMLf)
-
National Representative from India, International CML Foundation
-
Principal Investigator for multiple International & multiple national oncology clinical trials
-
Member, European Society for Medical Oncology (ESMO)
-
Member, International Union Against Cancer (UICC)
-
Member, American Society of Hematology (ASH)
-
Oncology Project Reviewer for International Union Against Cancer (UICC)
-
Member, International Society of Pediatric Oncology (SIOP)
-
Member, American Association for Cancer Research (AACR)
-
Member, American Society of Clinical Oncology (ASCO)
-
Founder Member; Managing Committee Member & In charge, Leukemia Lymphoma Protocol Committee, Indian Cooperative Oncology Network (ICON)
-
Member, Managing Committee, Indian Society of Medical & Pediatric Oncology
-
Honorary Secretary, Indian Society of Medical & Pediatric Oncology
-
Member, Editorial Board, Journal of the Association of Physicians of India
-
Member, Editorial Board, Journal of the Indian Society for Medical & Pediatric Oncology
-
Member, Editorial Board, Journal of the Indian Society for Hematology & Transfusion Medicine
-
Member, Editorial Board, Indian Journal of Cancer
-
Joint Secretary, Ethics Committee, SMS Medical College & Attached Hospitals, Jaipur, 2000 to 2010
-
Member, Ethics Committee, Bhagwan Mahaveer Cancer Hospital & Research Center, Jaipur
-
President Elect, Indian Society of Medical & Pediatric Oncology (ISMPO)
-
Founder Member & Honorary Vice President, Teenage and Young Adult Cancer Foundation
-
Rekha Gupta, Satyajeet Soni1, Hemant Malhotra1; Genetic counseling for hereditary cancers: Not everybody’s cup of tea!; Cancer Research, Statistics, and Treatment / Volume 6 / Issue 3 / July-September 2023 pg- 483-484 (Letters to Editor)
-
P.M. Parikh1 S. Aggarwal2 G. Biswas3 S. Gulia4 V. Agarwala5 M. Basade6 P.N. Mohapatra7 K. Muddu Vamshi8 A. Warrier9 Krishna Prasad10 Partha Roy11 M.V. Chandrakant12 H. Malhotra13 Sachin; Practical Clinical Consensus Guidelines for the Management of Cancer Associated Anemia (CAA) in Low- and Middle-Income Countries (LMIC); South Asian J Cancer 2023;00(00):00–00 (Open Access)
-
Purvish M. Parikh1 Dinesh M. Shah2 Urvish G. Parikh3 Ajit Venniyoor4 Govind Babu5 Apurva Garg6 Hemant Malhotra7; ChatGPT—Preliminary Overview with Implications for Medicine and Oncology; Ind J Med Paediatr Oncol 2023;44:377–383; DOI https://doi.org/10.1055/s-0043-1768985. ISSN 0971-5851
-
Tarun Kumar Jain1• Namita Agrawal2• Hemant Malhotra3• Ajay Yadav3• Dinesh Yadav4Anushree Punia5; Is F18 FDG PET-CT an Authoritative Investigation as Compared to Other Conventional Imaging (CECT) Modality in Treated Cervical Cancer Patients?; Indian Journal of Gynecologic Oncology (2023) 21:51;Pg-2-11 https://doi.org/10.1007/s40944-023-00731-7;Original Article
-
Purvish M. Parikh1 Dinesh M. Shah2 Urvish G. Parikh3 Ajit Venniyoor4 Govind Babu5 Apurva Garg6 Hemant Malhotra7; ChatGPT—Preliminary Overview with Implications for Medicine and Oncology; Ind J Med Paediatr Oncol (Open Access); June 2023; Review Article
-
Khushboo Agarwal1 Naveen Gupta1 Hemant Malhotra1; Hypercalcemia in Chronic Myeloid Leukemia: An Unusual Presentation; Ind J Med Paediatr Oncol (Open Access); January 2023; Case Report with Review of Literature
-
Nitin Khunteta1 Ayush Makkar1 Jaspreet Singh Badwal1 Prakhar Katta1 Dinesh Choudhary1 Mohinder Viswanath1 Hemant Malhotra2; Patterns of Neck Nodal Metastasis from Oral Cavity Carcinoma; South Asian J Cancer 2022;11(4):326–331; Original Article
-
Purvish Parikh, Hemant Malhotra, Lalit Mohan Sharma, Ajay Yadav, Naveen Gupta: Editorial. International Journal of Molecular and Immuno Oncology; Volume 7. Issue 3. September-December 2022
-
Hemant Malhotra, Dr. Naveen Gupta: Advances in the Field of Hematopoietic Stem Cell Transplantation. Progress in Medicine 2022 Volume 32 Chapter 101
-
Hemant Malhotra et al: Optimizing Real-World Evidence Framework for Oncology: Challenges, Opportunities, and Way Forward for India. White Paper(Pfizer); P.1-19
-
R Kanesvaran , E Castro , A Wong , K Fizazi , M L K Chua , Y Zhu , H Malhotra et al: Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer. ESMO Open . 2022 Aug;7(4):100518
-
Priyanka Soni, Naveen Gupta, Hemant Malhotra: The day 14 conundrum still remain unresolved!. Cancer Research, Statistics, and Treatment / Volume 5 / Issue 1 / January-March 2022 p.155-156
-
Amol Patel, Amol Akhade, Purvish Parikh, Atul Sharma, Hemant Malhotra et al: Pembrolizumab weight based dosing – A call for policy change. Indian J Med Paediatr Oncol 2022; 43(03): 306-310
-
Dr. Hemant Malhotra: Dr. Gouri Shankar Bhattacharyya, MD, PhD, FRCP [October 31, 1958—May 1, 2021]: A Tribute!!. Indian Journal of Medical and Paediatric Oncology 42(02): 135-136
-
Hemant Malhotra: Dr. Gouri Shankar Bhattacharyya, MD, PhD, FRCP: In Memoriam (October 31, 1958-May 1, 2021). J Thorac Oncol. 2021 Jul;16(7):1043-1044
-
Purvish M Parikh , Gouri Shankar Bhattacharyya, Ghanshyam Biswas , Hemant Malhotra et al: Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India. South Asian J Cancer. 2021 Dec 31;10(4):213-219
-
R Kanesvaran, C Porta , A Wong , T Powles , Q S Ng , M Schmidinger , D Ye , H Malhotra et al: Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma. ESMO Open. 2021 Dec;6(6):100304, Page 1-14
-
Ashok K Vaid, Hemant Malhotra et al: Indian Expert Opinion on Cancer Care during COVID-19 Pandemic. South Asian J Cancer 2021 Jan;10(1):3-8
-
TK Jain, G Singh, S Goyal, H Malhotra, A Yadav, P Kumbhaj, D Yadav,et al: Is F-18 FDG PET/computed tomography a useful tool to restage the patients with tongue carcinoma? Nuclear Medicine Communications 2021: Page 23-27
-
Gouri Shankar Bhattacharyya, Sneha J Bothra, Hemant Malhotra, K Govindbabu et al: Solving the Malady of Financial Toxicity Using Augmented Intelligence. JCO Clin Cancer Inform . 2021 Mar;5:348-352
-
Ashwin Mathur , Hemant Malhotra ,Avikesh Agarwal et al. Elucidation of Plasma Concentrations of Morphine, and it's Correlation with pain in cancer patients Receiving Palliative Care. RUHS Journal of Health Sciences , Early Online Publication 2021: page 23-27
-
A Punia, H Malhotra : International Regulatory Processes and Policies for Innovator Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists 2021, P. 159-176 (Chapter)
-
Tarun Kumar Jain , Guman Singh, Sumit Goyal, Ajay Yadav, Dinesh Yadav , Nitin Khunteta, Hemant Malhotra et al: Should fluorodeoxyglucose positron emission tomography/computed tomography be the first-line imaging investigation for restaging the laryngeal carcinoma patients? World J Nucl Med . 2021 Feb 12;20(2):164-171.
-
Tarun Kumar Jain, Anushree Punia, Shikha Dhal, Guman Singh, Hemant Malhotra, Ankur Punia, Naveen Gupta: Fluorodeoxyglucose positron emission tomography-computed tomography base response assessment in primary thyroid lymphoma. International Journal of Otorhinolaryngology and Head and Neck Surgery 2020 Dec;6(12):2313-2315
-
Hemant Malhotra, Ajay Yadav, Naveen Gupta, Satyajeet Soni, Jitender Kumar Singh, Bharti Malhotra: Chronic Myeloid Leukemia (CML) in Adolescents & Young Adults (AYA): Single Institution 10 Years Experience with 1st Line Imatinib Mesylate (IM). 2020. Blood Volume136 Pages 6
-
Namita Agrawal, Tarun Kumar Jain , Abhishek Charan , Sanjay Sharma , Hemant Malhotra , Nitin Khuteta , Ajay Yadav: Imaging resemblance but diagnostic disparity in cervix cancer: a rare case report. Int J Reprod Contracept Obstet Gynecol. 2020 Aug;9(8):3480-3482
-
Namita Agrawal, Tarun Kumar Jain, Guman Singh, Hemant Malhotra, Ajay Yadav: Unusual metastatic sex cord stromal tumor - staging and response assessment. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2020 Jul;9(7):3072-3074
-
Asha Sharma , Dr Rati Mathur , Dr Hemant Malhotra et al: Association between C- reactive protein and Matrix metalloproteinase-2 in Non –small cell lung carcinoma. JMSCR Vol||08||Issue||05||Page 206-211||May
-
B Malhotra, V Gupta, P Sharma, R Singh, H Sharma, M Vyas, RP Mathur, H Malhotra et al: Clinico-epidemiological and genomic profile of first Zika Virus outbreak in India at Jaipur city of Rajasthan state. Journal of Infection and Public Health 13 (12), 1920-1926; 2020
-
TK Jain, A Yadav, H Malhotra, N Khuteta, G Singh : Isolated malignant portal vein thrombus in colon carcinoma–A rare finding on 18F-FDG PET/CT. Journal of Nuclear Medicine Technology, 120;249-532,2020
-
H Malhotra, P Kowtal, N Mehra, R Pramank, R Sarin, T Rajkumar, S Gupta, et al : Genetic Counselling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology. JCO Global Oncology 6, 991-1008,2020
-
H Malhotra, N Gupta, S Bairwa : Treating lymphomas in low-and middle-income countries.. Cancer Research, Statistics, and Treatment 3 (2), 364,1,2020
-
J Bajpai, S Mailankody, R Nair, ST Surappa, S Gupta, K Prabhash, H Malhotra, et al : Gender climate in Indian oncology: national survey report. ESMO open 5 (2), e000671; 3; 2020
-
A Sharma, R Mathur, H Malhotra : Matrix Metalloproteinase-2: A Possible Marker for Non-Small Cell Lung Carcinoma. Journal of Clinical & Diagnostic Research 14 (3), 21-23,2020.
-
LT Chen, E Martinelli, AL Cheng, G Pentheroudakis, S Qin, H Malhotra, et al : Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative. Annals of Oncology 31 (3), 334-351; 13:2020
-
S Choudhary, J Singh, H Malhotra, R Sharma: Clinical & Lab Marker Predicting Early Molecular Response in patient of CML Chronic Phase Treated With Imatinib. The Journal of the Association of Physicians of India 68 (1), 102; 2020
-
H Malhotra, J Radich, P Garcia-Gonzalez: Meeting the needs of CML patients in resource-poor countries. Hematology 2019 (1), 433-442;12;2019.
-
Prostatic cancer androgen deprivation therapy and bone health in carcinoma prostate. GS Bhattacharyya, H Malhotra, KG Babu, A Ranade, A Vora, G Biswas, et al. Annals of Oncology 30, v731-v732; 2019
-
J Bajpai, RA Kannan, H Malhotra, V Radhakrishnan, R Jalali, G Narula, et al: Meeting Proceedings of the First Immuno-Oncology Society of India Conference (I-OSICON-2019), Mumbai, India. Journal of Immunotherapy & Precision Oncology 2 (3), 106; 2019
-
A Patel, TV Tilak, VG Gupta, A Batra, P Mehta, P Parikh, H Malhotra: Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth. Indian Journal of Medical and Paediatric Oncology 40 (2), 311, 2019
-
M Sengar, A Fundytus, WM Hopman, H Malhotra, S Gupta, CS Pramesh: Medical oncology in India: workload, infrastructure, and delivery of care. Indian Journal of Medical and Paediatric Oncology 40 (1), 121; 8; 2019
-
GS Bhattacharyya, H Malhotra, G Babu, A Vora, T Shahid, SM Ghosh: Relationship between depressive symptoms at social cognitive processing in partners of long-term breast cancer survivors. Annals of Oncology 29, viii559; 2018
-
GS Bhattacharyya, H Malhotra, G Babu, A Vora, S Bhattacharyya: Cancer stigma related to beliefs of patients and care providers. Annals of Oncology 29, viii559;5; 2018
-
MB Agarwal, H Malhotra, P Chakarborti, N Varma, V Mathews, et al: Revised myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia. Indian Journal of Medical and Paediatric Oncology 39 (4), 503;2;2018
-
H Malhotra, A Maru, N Khattry, MV Ramanan, E Leip, RJ Crescenzo, e t al: Efficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial. Annals of oncology, 2018
-
A Mathur, N Rastogi, D Gurjar, R Sai, A Lakesar, H Malhotra: Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: South Asian journal of cancer 7 (4), 254; 3; 2018
-
GS Bhattacharyya, H Malhotra, KG Babu, G Biswas: Impact of adrenergic and prostanoid inhibitors used chronobiologically on outcomes in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology 36 (15_suppl), e16581-e16581;2018.
-
D Biswas, M Mathur, S Bhargava, H Malhotra: Anticancer activity of root extracts in non-small cell lung cancer Asparagus racemosus A549 cells. Asian Journal of Pharmacy and Pharmacology 4 (6), 764-70; 3;2018
-
SH Advani, H Malhotra, RT Chacko, M Basade, P Keechilat, et al: Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed non-small cell lung carcinoma patients Indian Journal of Cancer 54 (5), 31;1:2017.
-
T Gathani, I Barnes, R Ali, R Arumugham, R Chacko, R Digumarti, H Malhotra, et al: Lifelong vegetarianism and breast cancer risk: a large multicentre case control study in India. BMC women's health 17 (1), 1-6; 10; 2017.
-
GS Bhattacharyya, PM Parikh, G Biswas, SA Bondarde, H Malhotra: Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer. Journal Of Thoracic Oncology 10 (9), S743-S743; 2015
-
GS Bhattacharyya, PM Parikh, G Biswas, R Dhar, SA Bondarde, H Malhotra, et al: Determine Whether Psychosocial Factors Predict Depression among Older Indian Lung Cancer Patients. Journal Of Thoracic Oncology 10 (9), S516-S516; 2015
-
H Malhotra, A Joshi, S Jasuja, A Yadav: Gefitinib [epidermal growth factor receptor (EGFR) inhibitor] plus etoricoxib (COX-2 inhibitor) versus oral methotrexate in advanced, recurrent head and neck squamous cell. Cancer Research 75 (15 Supplement), 2582-2582; 2015
-
H Malhotra, P Sharma, B Malhotra, S Bhargava, S Jasuja, M Kumar: Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase. The Indian journal of medical research 142 (2), 175;8; 2015.
-
A Mathur, A Yadav, S Jasuja, A Jindal, H Malhotra: Aggressive angiomyxoma perineum: A rare soft tissue neoplasm in males. Indian journal of cancer 52 (4), 2015
-
T Shahid, GS Bhattacharyya, H Malhotra, KS Govindbabu, PM Parikh et al: Continuous low dose temozolamide with or without VT-122 in glioblastoma. Journal of Clinical Oncology 33 (15_suppl), e13010-e13010;4; 2015
-
GS Bhattacharyya, H Malhotra, PM Parikh, KS Govind babu, A Ranade: Phase II study of metronomic cyclophosphamide and temozolomide in platinum resistance ovarian cancer. Journal of Clinical Oncology 33 (15_suppl), e16575-e16575;3; 2015
-
A Krishnan, R Mody, H Malhotra: Global regulatory landscape of biosimilars: emerging and established market perspectives. Biosimilars 5, 19-32; 30; 2015
-
GS Bhattacharyya, KG Babu, SA Bondarde, G Biswas, A Ranade, H Malhotra, et al: Effect of co-administered beta blocker and COX-2 inhibitor to patients with pancreatic cancer prior to receiving albumin-bound (Nab) paclitaxel. Journal of Clinical Oncology 33 (3_suppl), 302-302;12; 2015
-
GS Bhattacharyya, H Malhotra, K Govind babu, AAB Ranada, PM Parikh: Can we really apply international guidelines in limited resources countries?. The Breast, S33-S34; 2015
-
MB Agarwal, H Malhotra, P Chakrabarti, N Varma, V Mathews, et al: Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia. Indian journal of medical and paediatric oncology: 36 (1);3-16; 2015
-
H Malhotra, P Sharma, S Bhargava, OS Rathore, B Malhotra, M Kumar: Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia. Leukemia & lymphoma 55 (11), 2614-2619; 16; 2014
-
GS Bhattacharyya, H Malhotra, PM Parikh, K Govindbabu, G Biswas, et al: Prognostic value of C-reactive protein and lactic dehydrogenase and hemoglobin in advanced non small cell lung cancer. et al Journal of Geriatric Oncology 5, S35 ; 2014
-
GS Bhattacharyya, H Malhotra, PM Parikh, K Govindbabu, G Biswas, et al: Pilot phase II study of an exercise intervention for advanced lung cancer patients stage IIIB and C post concomitant CT/RT by a home based protocol Journal of Geriatric Oncology 5, S35-S36; 2014.
-
GS Bhattacharyya, SA Bondarde, G Biswas, KG Babu, D Dutta, H Malhotra, et al: Impact of adrenergic and prostanoid inhibitors on outcomes in patients with advanced hepatocellular carcinoma (HCC): A prospective clinical trial. Journal of Clinical Oncology 32 (15_suppl), e15148-e15148; 2014
-
GS Bhattacharyya, A Ranade, H Malhotra, K Govind Babu, T Shahid, et al: Continuous metronomic temozolamide with propranolol and etodolac in recurrent globlastoma: A pilot study. Journal of Clinical Oncology 32 (15_suppl), e13005-e13005; 3; 2014
-
CS Pramesh, RA Badwe, BB Borthakur, M Chandra, EH Raj, T Kannan, H Malhotra, et al: Delivery of affordable and equitable cancer care in India. The Lancet Oncology 15 (6), e223-e233;129; 2014
-
MK Mallath, DG Taylor, RA Badwe, GK Rath, V Shanta, CS Pramesh, H Malhotra, et al The growing burden of cancer in India: epidemiology and social context. The Lancet Oncology 15 (6), e205-e212; 295; 2014
-
Indian Council of Medical Research consensus document for the management of buccal mucosa cancer. GK Rath, PM Parikh, S Hukku, B Rajan, S Kumar, H Malhotra, S Vuthaluru, et al. Indian journal of medical and paediatric oncology: 9; 2014
-
KG Babu, K Prabhash, AK Vaid, B Sirohi, RB Diwakar, R Rao, M Kar, H Malhotra, et al: Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study OncoTargets and therapy 7, 1051; 28; 2014
-
GS Bhattacharyya, KG Babu, H Malhotra, AA Ranade, S Murshed, D Datta: Hepatocellular carcinoma in India. Chinese clinical oncology 2 (4), 41-41; 11; 2013
-
Hemant Malhotra, Pratibha Sharma, Shipra Bhargava, Bharti Malhotra, Madhu Kumar: Gene Expression Levels Of Imatinib Transporters and Molecular Response To Imatinib Therapy In Chronic Myeloid Leukemia Patients. Blood, The Journal of the American Society of Hematology; Volume 122; Issue 21 Pages 4959-4959
-
GS Bhattacharyya, AAB Ranade, G Biswas, H Malhotra, K Govind babu, et al: Increasing therapeutic efficacy and safety of docetaxel in lung cancer. Journal of Thoracic Oncology 8, S1014-S1014; 2013
-
T Shahid, GS Bhattacharyya, H Malhotra, K Govindbabu, PM Parikh, et al: Continuous low dose temozolamide in brain metastasis from lung cancer. Journal of thoracic oncology 8, S557-S557; 2013
-
GS Bhattacharyya, H Malhotra, PM Parikh, K Govindbabu, T Shahid, et al: Heterogenity of adeno carcinoma of lung-change in immunohistochemistry and histopathology character in patients treated with chemotherapy or EGFR-TKIS. Journal of thoracic oncology. 8, S1056-S1057; 2013
-
GS Bhattacharyya, H Malhotra, A Ranade, S Bondarde, G Biswas et al: Phase II study evaluating safety and efficacy of co-administering propranolol and etodolac for treating cancer cachexia in geriatric patients. Journal of geriatric oncology 4, S38; 1;2013
-
GS Bhattacharyya, S Bondarde, H Malhotra, G Biswas, N Bascomb: Improving efficacy of docetaxel in castration resistant prostate cancer patients. Journal of geriatric oncology 4, S36-S37. 2013
-
GS Bhattacharyya, A Ranade, H Malhotra, K Govind babu, PM Parikh, e t al: Metronomic chemotherapy in geriatric triple negative breast cancer patients with or without VT-122. Journal of Geriatric Oncology 4, S27-S28; 2013
-
H Malhotra, R Sharma, Y Singh, H Chaturvedi: Report of chronic myeloid leukemia SMS Medical College Hospital, Jaipur. Indian journal of medical and paediatric oncology: 34(3), 177-79; 2013
-
H Malhotra, P Sharma, S Bhargava, OS Rathode, B Malhotra, V Gota: Plasma trough imatinib levels and molecular response in patients of chronic myeloid leukemia (CML): A single institution study from India. Journal of Clinical Oncology 31 (15_suppl), 7079-7079; 2013.
-
K Prabhash, K Govind Babu, AK Vaid, RR Rangaraju, B Sirohi, R Diwakar, H Malhotra et al: Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: A phase II, open-label, multicenter, randomized study. Journal of Clinical Oncology 31 (15_suppl), 8053-8053; 3; 2013.
-
GS Bhattacharyya, N Bascomb, H Malhotra, G Biswas, SA Bondarde: Chemotherapy in hormone-refractory prostate cancer: Docetaxel with and without VT122. Journal of Clinical Oncology 31 (15_suppl), e16062-e16062;2013
-
H Malhotra, B Malhotra, S Bhargava, OS Rathode, P Sharma, A Mathur, et al: Anti-leukemic activities of alcoholic extracts of two traditional Indian medicinal plants. Cancer Research 73 (8 Supplement), 2248-2248; 2013.
-
JE Cortes, DW Kim, HM Kantarjian, TH Brümmendorf, I Dyagil, H Malhotra, et al: Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial. Journal of Clinical Oncology 30 (28), 3486;439; 2012
-
G Gravis, K Fizazi, F Joly Lobbedez, S Oudard, Hemant Malhotra et al: Genitourinary tumors, prostate. September 2012Annals of Oncology 23(suppl 9):ix294-ix318
-
GS Bhattacharyya, H Malhotra, PM Parikh, JK Singh, GB Kanaka, S Basu, et al: Serum Chromogranin a in Metastatic Carcinoma Prostate-a Prognostic Marker for Hormonal Therapy. Annals of Oncology 23, ix301; 2012
-
H Malhotra: Janus Activated Kinase inhibition in Myelofibrosis. Indian journal of cancer 4(3), 260;1;2012
-
H Malhotra: Biosimilars and non-innovator biotherapeutics in India: an overview of the current situation. Biologicals 39 (5), 321-324; 38; 2011
-
GS Bhattacharwa, H Malhotra, KG Babu, G Biswas, AA Ranade et al: COX-2 Inhibitor and Gefitinib in Recurrent And/or Metastatic Head & Neck Cancer. European Journal of Cancer 47, S569-S570; 2011
-
GS Bhattacharvva, J Biswas, JK Singh, M Singh, K Govindbabu, H Malhotra, et al: Reversal of tamoxifen resistance (hormone resistance) by addition of sirolimus (mTOR inhibitor) in metastatic breast cancer. European Journal of Cancer 47, 9;37;2011.
-
PM Parikh, S Gupta, B Parikh, BK Smruti, J Issrani, S Topiwala, H Malhotra, et al: Management of primary and metastatic triple negative breast cancer: Perceptions of oncologists from India. Indian journal of cancer 48 (2), 158; 5; 2011
-
C Gambacorti-Passerini, DW Kim, HM Kantarjian, TH Brummendorf, H Malhotra, et al: An ongoing phase 3 study of bosutinib (SKI-606) versus imatinib in patients with newly diagnosed chronic phase chronic myeloid leukemia. Blood, 116 (21), 208-208;42;2010
-
GS Bhattacharyya, JK Singh, M Singh, S Basu, AK Vaid, P Parikh, H Malhotra, et al: Serum chromogranin A-A marker for hormone-refractory carcinoma of prostate-and for prognosis. Annals of oncology 21, 302-302; 2010.
-
Tejas Patel, Sanjay Shah, Alok Ranjan, Hemant Malhotra, Samir Pancholy, John Coppola: Contralateral transradial approach for carotid artery stenting: a feasibility study. 2010; Catheterization and Cardiovascular Interventions V 75; Issue 2 Pages 268-275
-
GS Bhattacharyya, H Malhotra, D Agarwalla, K Govindbabu, P Parikh: Serum IL-8 as a prognostic marker for triple negative advanced breast cancer. Annals of Oncology. 21, 109-109; 2010
-
H Malhotra, R Sharma, PD Khandelwal: Capecitabine plus oxaliplatin combination chemotherapy for patients with inoperable gall bladder cancer-results of a single institution phase ii study. Annals of Oncology 21, 262-262; 2010
-
GS Bhattacharyya, H Malhotra, K Govindbabu, D Aggarwala, M Basade, et al: Safety and efficacy of intermittent Gefitinib vs Paclitaxel+ Carboplat weekly vs intermittent Gefitinib and Paclitaxel+ Carboplat. Critical Reviews in oncology/Hematology 72 (1), S43-S44; 2009
-
H Malhotra: Cisplatin ototoxicity. Indian Journal of Cancer 46 (4), 262; 9; 2009
-
H Malhotra, R Sharma, PD Khandelwal: Gefitinib in chemo-naive, poor performance status, Non Small Cell Lung Cancer (NSCLC) patients-A randomized, single institution pilot study. Journal Of Thoracic Oncology 4 (9), S697-S698; 2009
-
GS Bhattacharyya, H Malhotra, D Agarwalla: Amino Bisphosphonate as a modulator for angiogenesis in lung cancer: schedule dependant dosing. Journal Of Thoracic Oncology 4 (9), S794-S794; 2009
-
GS Bhattacharyya, H Malhotra, AA Ranade, D Raghunadharao: Everyone is concerned about costs! Indian journal of cancer 46 (3), 179; 1; 2009
-
A Lodha, K Verma, H Malhotra, B Mathur, A Agrawal: Effects of Lucerne leaf concentrate supplementation on the nutritional status of chronic myeloid leukemia (CML) patients. Nutrition & Food Science;3; 2009
-
GS Bhattacharyya, H Malhotra, K Govindbabu, D Aggarwala, M Basade, et al: Safety and efficacy of intermittent Gefitinib vs Paclitaxel Carboplat weekly vs intermittent Gefitinib and Paclitaxel Carboplat. Critical Reviews in Oncology hematology 72 (1), 4;2009
-
GS Bhattacharyya, S Basu, V Agarwal, H Malhotra, PM Pareekh, KG Babu: Single institute phase II study of weekly cisplatinum and metronomic dosing of endoxan and methotrexate in second line metastatic breast cancer triple-negative. EJC Supplements 3 (7), 18-19, 32 ;2009
-
P Kumar, GS Bhattacharyya, S Dattatreya, H Malhotra: Tackling the cancer Tsunami. Indian journal of cancer 46 (1), 1, 12; 2009
-
H Malhotra, AP Singh, JP Rishi, PD Khandelwal: Aplastic Anemia, Pesticide Exposure and Response to Cyclosporine Monotherapy: A Single Institution Case Controlled Study. Blood; 112 (11), 4115-4115; 1; 2008
-
P Parikh, GS Bhattacharyya, P Chaturvedi, H Malhotra, PM Parikh, S Jelic, et al: Prevention in lung cancer: a vision from India. Annals of oncology 19, 37-37; 2008
-
P Parikh, H Malhotra, S Jelic et al: Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology 19, ii27-ii28; 26 ;2008
-
H Malhotra, S Sharma, RG Sharma, JP Rishi: Irinotecan plus carboplatin chemotherapy for small cell lung cancer: Single institution experience of 14 patients. Annals Of Oncology 18, 185-185; 2007
-
S Sharma, DP Agarwal, OP Sharma, R Sharma, H Malhotra, N Somani, et al: Improving quality of sexual life among elderly cancer patients in developing countries: Dispelling the myths. Annals Of Oncology 18, 195-195; 2007
-
H Malhotra, R Sharma, D Agarwal, J Rishi: Treatment of children and young adults with acute lymphoblastic leukemia with an uniform protocol: ten year, single institution experience from a medical college. Pediatric Blood & Cancer 47 (4); 2006
-
S Shah, N Tanwar, A Ranjan, K Jani, H Malhotra, S Gupta, T Patel: Transradial iliac artery interventions. 2006 Conference AMERICAN JOURNAL OF CARDIOLOGY Volume 97 Issue 8 B Pages 92D-92D
-
A Ranjan, N Tanwar, R Pothiwala, H Malhotra, S Shah, T Patel : Radial artery size in adult Indians. 2006 AMERICAN JOURNAL OF CARDIOLOGY; Volume 97 Issue 8 B Pages 78D-78D
-
PM Parikh, H Malhotra, K Chaudhry, B Rajan, GS Bhattacharyya: A practical approach to prevention of cancer: Unity among diversity. Annals of Oncology 17, 43-43; 2006
-
S Nijhawan, A Joshi, A Shende, H Malhotra, A Mathur, RR Rai. EBV-associated hepatitis with aplastic anemia. J Asso Phys India 53:10, 1079; 2005
-
S Shah, H Malhotra, et al: Safety and efficacy of an indigenous recombinant interferon-alpha-2b in patients with chronic myelogenous leukaemia: results of a multicentre trial from India. National Medical Journal Of India 18 (3), 66 P 130-130
-
L Kumar, VP Gangadharan, DR Rao, T Saikia, S Shah, H Malhotra, et al: Safety and efficacy of an indigenous recombinant interferon-alpha-2b in patients with chronic myelogenous leukaemia: results of a multicentre trial from India. National Medical Journal Of India 18 (2), 66;10; 2005
-
H Malhotra: Multiple Myeloma–inching towards a cure. Medicine, 814; 2005
-
H Malhotra, RG Sharma, DP Agarwal: Locally Advanced Breast Cancer (LABC): Single Institution experience of treating 19 patients with a uniform protocol. Annals of Oncology 15, 53-53;2004
-
PM Parikh, RM Gaafar, H Malhotra: Opportunities for oncology research in developing countries. Annals of oncology 15, 10-10; 2004
-
TM Patel, SC Shah, A Ranjan, H Malhotra, R Patel, AK Gupta: Stenting through a portacath for totally occluded superior vena cava in a case of non-Hodgkin s lymphoma. The Journal of invasive cardiology 15 (2), 86-88; 3; 2003
-
S Jasuja, A Mathur, SS Bhakal, PS Manghera, H Malhotra: Xeroderma pigmentosum with squamous cell carcinoma of face: A rare case report of two siblings. 2003; Journal Clin Infect Dis Volume 37 P. 820-27
-
D Pendharkar, BV Aousekar, S Aggarwal, H Malhotra, I Walia, R Kumar: Erythropoetin (EPO) in Indian patients-A case for review. Blood 100 (11), 20B-20B; 2002
-
P Parikh, G Bhattacharyya, P Shah, R Deshpande, S Sharma, V Sharma, H Malhotra, et al: Low dose prolonged infusion gemcitabine in combination with carboplatin for advanced NSCLC: A safe and cost-effective alternative (on behalf of Indian Co-operative Oncology Annals of Oncology 13;4; 2002
-
S Basu, N Gupta, H Malhotra: IgA myeloma presenting as diabetes mellitus with refractory anaemia. The Journal of the Association of Physicians of India 50, 981-982; 2002
-
H Malhotra, RG Sharma: One decade experience of running a leukemia lymphoma clinic at a medical college hospital in a developing country: problems, pitfalls and potentials. International Journal Of Cancer, 132-132; 2002
-
H Malhotra, R Sharma, D Agrawal: Lymphoblastic lymphoma (ll) treated with an inexpensive and simple protocol: results of treatment of the first 20 patients at a medical college hospital in India. Annals of Oncology 13; 2002
-
H Malhotra, RG Sharma, DP Agarwal: Treatment and long-term follow-up of Lymphoblastic Lymphoma (LL) in a developing country: Report of a single institutional experience in India. Blood 98 (11), 244B-244B; 2001
-
H Malhotra, RG Sharma, DP Agarwal: Acute lymphoblastic leukemia treated with the MCP-841 protocol at a Medical College Hospital with minimal facilities: 1992-1995 Data from the SMS Medical College Hospital. Blood 96 (11), 720A-721A; 2000
-
S Madajewicz, P Hentschel, P Burns, R Caruso, J Fiore, M Fried, H Malhotra, S Ostrow, S Sugarman, M Viola: Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies. Journal of clinical oncology Volume 18 Issue 20 Pages 3553-3557; 2000
-
H Malhotra, SC Gulati: Adult non-hodgkin's lymphoma: current therapeutic strategies. Indian Journal of Medical and Paediatric Oncology 18 (4), 101, 1997
-
H Malhotra: Gestational trophoblastic tumours: God's first cancer, Man's first cure. Indian Journal of Medical and Paediatric Oncology 18 (3), 65; 1997
-
S Nijhawan, DS Pokharna, H Malhotra, A Verma: Hematuria: a presentation of carcinoma of the stomach. Interleukins; 2; 1996
-
B Dhabhar, H Malhotra, AK Dhar: Interleukins. The Journal of the Association of Physicians of India, 58-64; 1995
-
H Malhotra: Survival in chronic myeloid leukemia. The Journal of the Association of Physicians of India Volume 42; Issue 4 Pages345-345 1994
-
BN Dhabhar, H Malhotra, R Joseph, S Garde, S Bhasin, A Sheth, et al: Gonadal function in prepubertal boys following treatment for Hodgkin's disease. The American journal of pediatric hematology/oncology 15 (3), 306-310; 37; 1993
-
H Malhotra, BN Dhabhar, RS Iyer, R Gopal, T Saikia, KS Nadkarni, et al: Pure red cell aplasia and non-Hodgkin's lymphoma: a case report and brief literature review. Indian journal of cancer 29 (3), 159-163; 2; 1992
-
H Malhotra, BN Dhabhar, TK Saikia, R Gopal, KS Nadkarni, CN Nair,et al: Ifosfamide in plasma cell leukemia: a report of two cases and review of the literature. American Journal of Hematology 40 (3), 226-228; 14;1992
-
BN Dhabhar, H Malhotra, SH Advani: Incidence of Lung Cancer and Advances in Non-Small Cell Lung Cancer. The Journal of the Association of Physicians of India 40 (7), 493; 1992
-
H Malhotra, BN Dhabhar, SH Advani: Profile of non-Hodgkin's lymphoma in India. The Journal of the Association of Physicians of India 40 (4), 282-283; 1992
-
H Malhotra, SH Advani, R Gopal, TK Saikia, KS Nadkarni, VR Pai, et al: Alpha-interferon in hairy cell leukemia: an initial Indian experience. Journal of the Association of Physicians of India 40 (3), 159-161;3;1992
-
BN Dhabhar, H Malhotra, U Hegde, SH Advani: Malignant lymphoma and coexistent tuberculous lymphadenitis. The Journal of the Association of Physicians of India 39 (10), 783-783;3; 1991
-
H Malhotra, SH Advani: Correct terminology in leukaemia treatment. The Journal of the Association of Physicians of India 39 (3), 291-292; 1991
-
SH Advani, H Malhotra, PR Kadam, RS Iyer, G Nanjangud, B Balsara: T-lymphoid blast crisis in chronic myeloid leukemia.. American journal of hematology 36 (2), 86-92; 24;1991
-
H Malhotra, SH Advani: Pure Red Cell Aplasia and Rheumatoid Arthritis. The Journal of the Association of Physicians of India 38 (10), 816; 1990
-
H Malhotra, B Dhabhar, SH Advani: Bone Marrow Biopsy in the Staging of Malignant Lymphoma. The Journal of the Association of Physicians of India 38 (8), 603;1990
-
SR Mehta, A Verma, H Malhotra, S Mehta: Normokalaemic periodic paralysis as the presenting manifestation of hyperthyroidism. The Journal of the Association of Physicians of India 38 (4), 296-297;13; 1990
-
S Mehta, SR Mehta, H Malhotra, UB Sharma, AR Varma: Congenital afibrinogenaemia. The Journal of the Association of Physicians of India 37 (10), 668-669;3; 1989
-
H Malhotra: Coronary Risk Factors and Ischaemic Heart Disease.. The Journal of the Association of Physicians of India 36 (3), 236; 1988
-
SR Mehta, H Malhotra, S Agarwal, D Mathur, PD Khandelwal: Effect of sublingual nifedipine on infarct size in acute myocardial infarction as determined by precordial ECG mapping. J Asso Phys India, 35(2), 129-31, 1987
-
H Malhotra, D Mathur, SR Mehta, PD Khandelwal: Pressor effects of alcohol in normotensive and hypertensive subjects. The Lancet 326 (8455), 584-586;83;1985
-
H Malhotra, R Vohra, PK Kohli, AK Banerjee: Hashimoto's thyroiditis presenting as thyrotoxicosis. May 1982 The Journal of the Association of Physicians of India 30(4):234-5
-
RR Wamorkar, GURSHARAN Singh, AR Kalurkar, NS Jagasia, HK Malhotra: Development of techniques for furthering the use of isotope radiography. 1977 Proceedings of the national symposium on industrial isotope radiography [held at] Tiruchirapalli [during] February 26-27, 1976